Diabetes Mellitus, Type 2 Clinical Trial
Official title:
CHD Lifestyle Modification for Latinas With Diabetes
The Viva Bien! trial will comprehensively evaluate a multiple risk factor intervention (diet, physical activity, stress management, social support, and smoking cessation) in a randomized effectiveness trial, which will be offered in English and Spanish to diabetic Latinas.
BACKGROUND:
Age-adjusted mortality from coronary heart disease (CHD) has been increasing in women with
diabetes. On the other hand, it has been decreasing in women without diabetes and in men
with and without diabetes. CHD remains the leading cause of death among women in the United
States. Risks of CHD and resulting death are significantly higher among postmenopausal
women; these rates are two and a half times higher among women with diabetes versus women
without diabetes. Diabetes is an independent risk factor for CHD in both Latina and Anglo
women, but it appears to be a greater risk factor for U.S. born Latinas, as they have higher
mortality from diabetes. Among Latinas, diabetes ranks as the third leading cause of death.
DESIGN NARRATIVE:
Hispanic Americans, in particular postmenopausal Hispanic women, have an increased
prevalence of type 2 diabetes, and a greater incidence of diabetes complications than
non-Hispanic whites. The LLP will comprehensively evaluate a multiple risk factor
intervention (diet, physical activity, stress management, social support, and smoking
cessation) in a randomized effectiveness trial that will be offered in English and Spanish.
The research team has shown that a similar theory-based comprehensive program, Mediterranean
Lifestyle Program (MLP), is effective in improving behavioral, psychosocial, quality of
life, and physiologic outcomes in postmenopausal Anglo women with type 2 diabetes. Though
the results are promising, four important research issues must be addressed before such a
program is ready to be put into practice. This study focuses on the following questions: 1)
How should the structure and content of the MLP be modified to address the cultural
characteristics of Latinas?; 2) Will the program succeed if offered within a large health
plan that serves minority populations (i.e., the Kaiser Permanente site in Denver, CO)?; and
3) What are the economic implications of the LLP? The Reach, Effectiveness, Adoption,
Implementation, and Maintenance (RE-AIM) evaluation framework will be used to assess how the
program impacts certain dimensions that are important for carry over into clinical practice.
Primary outcomes of this study will include change in behavioral measures. Secondary
outcomes will include impacts on quality of life, physiologic measures, member satisfaction,
and cost-effectiveness. The investigators will also study the relationship between cultural
variables in this Hispanic population (e.g., family and social support; group cohesion; and
acculturation) and program participation and outcomes. Substantial impacts of this study on
public health include: 1) intervening with a high-risk, underserved population; 2) focusing
on multiple critically important lifestyle behaviors known to reduce risk for CHD; 3)
testing maintenance of behavioral changes; 4) employing methodology to estimate the
program's readiness to be put into practice; and (5) measuring the robustness, reach, and
cost-effectiveness of the program.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |